Target intelligence / Profile preview

Urothelial surface (null)

Target
null
Molecular classification
Other, Tetraspanin family (e.g., uroplakin Ia, Ib), Ion channels (e.g., TRP channels), G protein-coupled receptors (e.g., muscarinic receptors), Toll-like receptors
01

Overview

The urothelial surface refers to the apical (luminal) layer of the urothelial lining, primarily composed of large, flattened umbrella cells interconnected by tight and adherens junctions. This surface is covered by specialized protein plaques (asymmetric unit membrane), mainly made of uroplakins, and forms one of the body’s tightest permeability barriers, crucial for containing urine and protecting against pathogens and toxins. The urothelial surface is not a single molecular target, but incorporates numerous specific proteins and receptors (including uroplakins, various ion channels, and GPCRs), each potentially representing a drug target or biomarker in its own right[3][5][6][7][8]. Damage or dysfunction at the urothelial surface underlies a number of urological diseases, including bladder cancer, interstitial cystitis, and urinary tract infections.

Other names
Urothelial apical surfaceBladder surface epitheliumUrothelial barrier
02

Mechanism of action

Not applicable to the "urothelial surface" as a whole; mechanisms relate to specific surface proteins: Muscarinic receptor agonists/antagonists; TRP channel modulators; Agents targeting uroplakin–bacterial adhesin interactions

03

Biological functions

Barrier to urine and toxic solutesProtection from pathogensSignal transduction (via receptors expressed on the surface)Regulation of water and ion passageSensory roles (chemical, mechanical, thermal stimuli)
04

Disease associations

Cancer (e.g., bladder cancer)Infection (e.g., urinary tract infection)Inflammation (e.g., interstitial cystitis)
05

Safety considerations

Damage to the urothelial barrier increases the risk of infection, inflammation, and cancerDrug-induced toxicity targeting surface molecules can compromise barrier integrity
06

Biomarkers

Uroplakins (UPK)Cytokeratin-20Certain receptor profiles

Beyond the preview

Go deeper on Urothelial surface (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urothelial surface (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call